132 related articles for article (PubMed ID: 20232485)
81. Synthetic combinations of missense polymorphic genetic changes underlying Down syndrome susceptibility.
Jackson RA; Nguyen ML; Barrett AN; Tan YY; Choolani MA; Chen ES
Cell Mol Life Sci; 2016 Nov; 73(21):4001-17. PubMed ID: 27245382
[TBL] [Abstract][Full Text] [Related]
82. Genetic causes of cancer predisposition in children and adolescents.
Saletta F; Dalla Pozza L; Byrne JA
Transl Pediatr; 2015 Apr; 4(2):67-75. PubMed ID: 26835363
[TBL] [Abstract][Full Text] [Related]
83. Clinical characteristics and laboratory analyses of acute myeloid leukemia with t(16;21)(p11;q22).
Zhang Z; Zou J; Li Y; Liu Z; Xu R; Tian W; Zhao Z; Sun H; Han J; Wang J; Zhang B; Ju Y
Oncol Lett; 2015 May; 9(5):2244-2248. PubMed ID: 26137050
[TBL] [Abstract][Full Text] [Related]
84. A case of pentasomy 21 with two isochromosome 21s in acute megakaryoblastic leukemia associated with Down syndrome.
Park Y; Lim J; Ko YH; Kim J; Kwon GC; Koo SH
Ann Lab Med; 2015 May; 35(3):373-5. PubMed ID: 25932450
[No Abstract] [Full Text] [Related]
85. Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies.
Chatterjee A; Dutta S; Mukherjee S; Mukherjee N; Dutta A; Mukherjee A; Sinha S; Panda CK; Chaudhuri K; Roy AL; Mukhopadhyay K
BMC Med Genet; 2013 Jan; 14():12. PubMed ID: 23343470
[TBL] [Abstract][Full Text] [Related]
86. Age-related neurodegeneration and memory loss in down syndrome.
Lockrow JP; Fortress AM; Granholm AC
Curr Gerontol Geriatr Res; 2012; 2012():463909. PubMed ID: 22545043
[TBL] [Abstract][Full Text] [Related]
87. Hematological disorders and leukemia in children with Down syndrome.
Bruwier A; Chantrain CF
Eur J Pediatr; 2012 Sep; 171(9):1301-7. PubMed ID: 22113227
[TBL] [Abstract][Full Text] [Related]
88. Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?
Hultén MA; Jonasson J; Nordgren A; Iwarsson E
Curr Genomics; 2010 Sep; 11(6):409-19. PubMed ID: 21358985
[TBL] [Abstract][Full Text] [Related]
89. The role of chromosome 21 in hematology and oncology.
Fonatsch C
Genes Chromosomes Cancer; 2010 Jun; 49(6):497-508. PubMed ID: 20232485
[TBL] [Abstract][Full Text] [Related]
90. Trisomy of chromosome 21 in leukemogenesis.
Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
[TBL] [Abstract][Full Text] [Related]
91. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
[TBL] [Abstract][Full Text] [Related]
92. [Association of congenital chromosome abnormalities and malignant diseases].
Erzsébet B; Andrea N; Róbert S; Eva O
Orv Hetil; 1996 Feb; 137(5):227-31. PubMed ID: 8882440
[TBL] [Abstract][Full Text] [Related]
93. [Constitutional chromosome abnormalities and acute leukemia].
Turc-Carel C; Mugneret F; Sidaner I
Pathol Biol (Paris); 1982 Nov; 30(9):792-7. PubMed ID: 6218469
[TBL] [Abstract][Full Text] [Related]
94. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
95.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
96.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
97.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
